Pharma patent news. .

Pharma patent news. .

Pharma patent news. From life-saving diabetes medications to essential respiratory treatments, these drugs have had a significant impact on modern care. 2 days ago · 3 major patent losses this year — and a key strategy to fill the gaps Despite promising pipelines, most new launches are missing sales targets, forcing pharmas to rethink sales strategies. Mar 21, 2025 · In this week’s episode of The Top Line, we dig into the report, which details the stories behind 10 key medicines that are set to face off against new generic or biosimilar competitors this year as Mar 7, 2025 · The global pharmaceutical industry is heading toward a $236 billion patent cliff between 2025 and 2030, as patents on blockbuster drugs expire, exposing nearly 70 high-revenue products to competition. The pharma has also developed a high-dose (HD) version of Eylea to keep the product’s competitive edge. Feb 21, 2023 · Today, big drugmakers are facing an even larger “patent cliff,” with more than $200 billion in annual revenue at risk through 2030. Dec 12, 2024 · In 2025, a lineup of high-profile drugs will lose their patents, representing billions in sales and years of therapeutic innovation. Apr 23, 2025 · Over 200 drugs, including 69 blockbusters, face patent expirations by 2025, potentially reshaping the $200B pharma market and impacting global healthcare. . Feb 19, 2025 · In December 2023, the pharma sued Samsung Bio for alleged patent infringement. Regeneron also has a case against Sandoz, seeking to block the generics developer from marketing its biosimilar. uocd cypw epnjak etvfzcd bvjsuyr ngswj tzxb kybdl hazfz iko